Smart Asthma Monitoring Device Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Cases of Asthma and COPD Globally – The existence of asthma and COPD diseases are growing rapidly with the increasing geriatric population, growth in the allergic reaction in response to pollen, dust, and other allergens, is leading to the growth in the market. In the year 2020, approx. of 40.7% adults of 18 and above years were diagnosed with asthmatic problems.
- Rise in Indoor Air Pollutants – As the indoor air gets polluted it leads to harmful respiratory health problems and other chronic health issues, asthma is one of the health problems caused by bad indoor air. Therefore, this raises the demand for smart asthma monitoring devices in the further times. In 2020, indoor air pollution was considered to be the cause of 3.2 million annual deaths, including approximately 237 000 deaths of children under the age of five.
- Increasing Technological Advancement – Advancements in technology in the healthcare system have led to the emergence of digital devices that aware patients from possible asthma attacks. These instruments contain the capability to monitor adherence, accurately record the time at which patients take a dose and also it offers access to real-time data that needs to be transported to personal device. All these advancements are expected to propel the market growth in the predicted period.
Challenges
- Lack of Awareness about the Benefits of Smart Inhalers and Nebulizers - Asthma prevalence is on the rise as a result of increased pollution levels around the world, which has prompted businesses to create high-tech, low-cost monitoring tools to support patients' active commitment to self-monitoring practices. The market for smart asthma monitoring devices is predicted to grow slowly due to a lack of awareness regarding the proper usage of smart inhalers and nebulizers.
- High Cost of Smart Monitoring Devices
- Lack of Knowledge about the Device
Smart Asthma Monitoring Device Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
24.6% |
|
Base Year Market Size (2024) |
USD 1.47 billion |
|
Forecast Year Market Size (2037) |
USD 25.65 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.
The smart asthma monitoring device market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of asthma, backed by rapid urbanization will drive the market growth.
North America industry is likely to hold largest revenue share of 38% by 2037, driven by high incidence of asthma in developed nations.
The major players in the market are Astellas Pharma Inc., Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, BioTelemetry, Inc., Health Care Originals Inc., Reciprocal Labs Corporation